Fig. 3From: Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical settingCumulative incidence of MBEs over time from the start of treatment, treated set. No events occurred after day 29 in THR patients or day 14 in TKR patients. MBE major bleeding event, THR total hip replacement, TKR total knee replacementBack to article page